Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Whole exome sequencing reveals novel COL4A3 and COL4A4mutations and resolves diagnosis in Chinese families with kidney disease

Authors: Fujun Lin, Fan Bian, Jun Zou, Xiangru Wu, Jianping Shan, Wei Lu, Yao Yao, Gengru Jiang, Daniel Philip Gale

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Collagen IV-related nephropathies, including thin basement membrane nephropathy and Alport Syndrome (AS), are caused by defects in the genes COL4A3, COL4A4 and COL4A5. Diagnosis of these conditions can be hindered by variable penetrance and the presence of non-specific clinical or pathological features.

Methods

Three families with unexplained inherited kidney disease were recruited from Shanghai, China. Whole exome sequencing (WES) was performed in the index case from each family and co-segregation of candidate pathogenic mutations was tested by Sanger sequencing.

Results

We identified COL4A4 missense variants [c.G2636A (p.Gly879Glu) and c.C4715T (p.Pro1572Leu)] in the 21-year-old male proband from family 1, who had been diagnosed with mesangial proliferative nephropathy at age 14. COL4A4 c.G2636A, a novel variant, co-segregated with renal disease among maternal relatives. COL4A4 c.C4715T has previously been associated with autosomal recessive AS and was inherited from his clinically unaffected father. In family 2, a novel COL4A3 missense mutation c.G2290A (p.Gly997Glu) was identified in a 45-year-old male diagnosed with focal segmental glomerulosclerosis and was present in all his affected family members, who exhibited disease ranging from isolated microscopic hematuria to end stage renal disease (ESRD). In family 3, ESRD occurred in both male and females who were found to harbor a known AS-causing COL4A5 donor splice site mutation (c.687 + 1G > A). None of these variants were detected among 100 healthy Chinese individuals.

Conclusion

WES identified 2 novel and 2 known pathogenic COL4A3/COL4A4/COL4A5 mutations in 3 families with previously unexplained inherited kidney disease. These findings highlight the clinical range of collagen IV-related nephropathies and resolved diagnostic confusion arising from atypical or incomplete clinical/histological findings, allowing appropriate counselling and treatment advice to be given.
Appendix
Available only for authorised users
Literature
1.
go back to reference Deltas C, Pierides A, Voskarides K: Molecular genetics of familial hematuric diseases. Nephrol Dial Transplant. 2013, 28: 2946-2960. 10.1093/ndt/gft253.CrossRefPubMed Deltas C, Pierides A, Voskarides K: Molecular genetics of familial hematuric diseases. Nephrol Dial Transplant. 2013, 28: 2946-2960. 10.1093/ndt/gft253.CrossRefPubMed
2.
go back to reference Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Elia A, Kyriacou K, Deltas C: Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2009, 24: 2721-2729. 10.1093/ndt/gfp158.CrossRefPubMed Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Elia A, Kyriacou K, Deltas C: Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2009, 24: 2721-2729. 10.1093/ndt/gfp158.CrossRefPubMed
3.
go back to reference Savige J, Ars E, Cotton RG, Crockett D, Dagher H, Deltas C, Ding J, Flinter F, Pont-Kingdon G, Smaoui N, Torra R, Storey H, The International Alport Mutation Consortium: DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome. Pediatr Nephrol. 2014, 29: 971-977. 10.1007/s00467-013-2486-8.CrossRefPubMed Savige J, Ars E, Cotton RG, Crockett D, Dagher H, Deltas C, Ding J, Flinter F, Pont-Kingdon G, Smaoui N, Torra R, Storey H, The International Alport Mutation Consortium: DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome. Pediatr Nephrol. 2014, 29: 971-977. 10.1007/s00467-013-2486-8.CrossRefPubMed
4.
go back to reference Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F: Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013, 24: 364-375. 10.1681/ASN.2012020148.CrossRefPubMed Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F: Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013, 24: 364-375. 10.1681/ASN.2012020148.CrossRefPubMed
5.
go back to reference Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frascá G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M: COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int. 2002, 61: 1947-1956. 10.1046/j.1523-1755.2002.00379.x.CrossRefPubMed Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frascá G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M: COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int. 2002, 61: 1947-1956. 10.1046/j.1523-1755.2002.00379.x.CrossRefPubMed
6.
go back to reference Chatterjee R, Hoffman M, Cliften P, Seshan S, Liapis H, Jain S: Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria. PLoS One. 2013, 8: e76360-10.1371/journal.pone.0076360.CrossRefPubMedPubMedCentral Chatterjee R, Hoffman M, Cliften P, Seshan S, Liapis H, Jain S: Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria. PLoS One. 2013, 8: e76360-10.1371/journal.pone.0076360.CrossRefPubMedPubMedCentral
7.
go back to reference Gibson J, Gilbert RD, Bunyan DJ, Angus EM, Fowler DJ, Ennis S: Exome analysis resolves differential diagnosis of familial kidney disease and uncovers a potential confounding variant. Genet Res (Camb). 2013, 95: 165-173. 10.1017/S0016672313000220.CrossRef Gibson J, Gilbert RD, Bunyan DJ, Angus EM, Fowler DJ, Ennis S: Exome analysis resolves differential diagnosis of familial kidney disease and uncovers a potential confounding variant. Genet Res (Camb). 2013, 95: 165-173. 10.1017/S0016672313000220.CrossRef
8.
go back to reference Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA: Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int. 2014, doi:10.1038/ki.2014.305 Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA: Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int. 2014, doi:10.1038/ki.2014.305
9.
go back to reference Fallerini C, Dosa L, Tita R, Del Prete D, Feriozzi S, Gai G, Clementi M, La Manna A, Miglietti N, Mancini R, Mandrile G, Ghiggeri G, Piaggio G, Brancati F, Diano L, Frate E, Pinciaroli A, Giani M, Castorina P, Bresin E, Giachino D, De Marchi M, Mari F, Bruttini M, Renieri A, Ariani F: Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet. 2014, 86: 252-257. 10.1111/cge.12258.CrossRefPubMed Fallerini C, Dosa L, Tita R, Del Prete D, Feriozzi S, Gai G, Clementi M, La Manna A, Miglietti N, Mancini R, Mandrile G, Ghiggeri G, Piaggio G, Brancati F, Diano L, Frate E, Pinciaroli A, Giani M, Castorina P, Bresin E, Giachino D, De Marchi M, Mari F, Bruttini M, Renieri A, Ariani F: Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet. 2014, 86: 252-257. 10.1111/cge.12258.CrossRefPubMed
10.
go back to reference Morinière V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E, Knebelmann B, Macher MA, Noel LH, Gubler MC, Antignac C, Heidet L: Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol. 2014 Morinière V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E, Knebelmann B, Macher MA, Noel LH, Gubler MC, Antignac C, Heidet L: Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol. 2014
11.
go back to reference Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup: The sequencing alignment/map format and SAMtools. Bioinformatics. 2009, 25: 2078-2079. 10.1093/bioinformatics/btp352.CrossRefPubMedPubMedCentral Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup: The sequencing alignment/map format and SAMtools. Bioinformatics. 2009, 25: 2078-2079. 10.1093/bioinformatics/btp352.CrossRefPubMedPubMedCentral
12.
go back to reference Wang K, Li M, Hakonarson H: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010, 38: e164-10.1093/nar/gkq603.CrossRefPubMedPubMedCentral Wang K, Li M, Hakonarson H: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010, 38: e164-10.1093/nar/gkq603.CrossRefPubMedPubMedCentral
13.
go back to reference Buzza M, Dagher H, Wang YY, Wilson D, Babon JJ, Cotton RG, Savige J: Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int. 2003, 63: 447-453. 10.1046/j.1523-1755.2003.00780.x.CrossRefPubMed Buzza M, Dagher H, Wang YY, Wilson D, Babon JJ, Cotton RG, Savige J: Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int. 2003, 63: 447-453. 10.1046/j.1523-1755.2003.00780.x.CrossRefPubMed
14.
go back to reference Demosthenous P, Voskarides K, Stylianou K, Hadjigavriel M, Arsali M, Patsias C, Georgaki E, Zirogiannis P, Stavrou C, Daphnis E, Pierides A, Deltas C, Hellenic Nephrogenetics Research Consortium: X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5. Clin Genet. 2012, 81: 240-248. 10.1111/j.1399-0004.2011.01647.x.CrossRefPubMed Demosthenous P, Voskarides K, Stylianou K, Hadjigavriel M, Arsali M, Patsias C, Georgaki E, Zirogiannis P, Stavrou C, Daphnis E, Pierides A, Deltas C, Hellenic Nephrogenetics Research Consortium: X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5. Clin Genet. 2012, 81: 240-248. 10.1111/j.1399-0004.2011.01647.x.CrossRefPubMed
15.
go back to reference Cheong HI, Park HW, Ha IS, Choi Y: Mutational analysis of COL4A5 gene in Korean Alport syndrome. Pediatr Nephrol. 2000, 14: 117-121. 10.1007/s004670050025.CrossRefPubMed Cheong HI, Park HW, Ha IS, Choi Y: Mutational analysis of COL4A5 gene in Korean Alport syndrome. Pediatr Nephrol. 2000, 14: 117-121. 10.1007/s004670050025.CrossRefPubMed
16.
go back to reference Lemmink HH, Schröder CH, Brunner HG, Nelen MR, Zhou J, Tryggvason K, Haagsma-Schouten WA, Roodvoets AP, Rascher W, Van Oost BA, Smeets HJ: Identification of four novel mutations in the COL4A5 gene of patients with Alport syndrome. Genomics. 1993, 17: 485-489. 10.1006/geno.1993.1351.CrossRefPubMed Lemmink HH, Schröder CH, Brunner HG, Nelen MR, Zhou J, Tryggvason K, Haagsma-Schouten WA, Roodvoets AP, Rascher W, Van Oost BA, Smeets HJ: Identification of four novel mutations in the COL4A5 gene of patients with Alport syndrome. Genomics. 1993, 17: 485-489. 10.1006/geno.1993.1351.CrossRefPubMed
17.
go back to reference Pont-Kingdon G, Sumner K, Gedge F, Miller C, Denison J, Gregory M, Lyon E: Molecular testing for adult type Alport syndrome. BMC Nephrol. 2009, 10: 38-10.1186/1471-2369-10-38.CrossRefPubMedPubMedCentral Pont-Kingdon G, Sumner K, Gedge F, Miller C, Denison J, Gregory M, Lyon E: Molecular testing for adult type Alport syndrome. BMC Nephrol. 2009, 10: 38-10.1186/1471-2369-10-38.CrossRefPubMedPubMedCentral
18.
go back to reference Boye E, Mollet G, Forestier L, Cohen-Solal L, Heidet L, Cochat P, Grünfeld JP, Palcoux JB, Gubler MC, Antignac C: Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet. 1998, 63: 1329-1340. 10.1086/302106.CrossRefPubMedPubMedCentral Boye E, Mollet G, Forestier L, Cohen-Solal L, Heidet L, Cochat P, Grünfeld JP, Palcoux JB, Gubler MC, Antignac C: Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet. 1998, 63: 1329-1340. 10.1086/302106.CrossRefPubMedPubMedCentral
19.
go back to reference Zhang Y, Wang F, Ding J, Zhang H, Zhao D, Yu L, Xiao H, Yao Y, Zhong X, Wang S: Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. Am J Med Genet A. 2012, 158A: 2188-2193. 10.1002/ajmg.a.35528.CrossRefPubMed Zhang Y, Wang F, Ding J, Zhang H, Zhao D, Yu L, Xiao H, Yao Y, Zhong X, Wang S: Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. Am J Med Genet A. 2012, 158A: 2188-2193. 10.1002/ajmg.a.35528.CrossRefPubMed
20.
go back to reference Heiskari N, Zhang X, Zhou J, Leinonen A, Barker D, Gregory M, Atkin CL, Netzer KO, Weber M, Reeders S, Grönhagen-Riska C, Neumann HP, Trembath R, Tryggvason K: Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome. J Am Soc Nephrol. 1996, 7: 702-709.PubMed Heiskari N, Zhang X, Zhou J, Leinonen A, Barker D, Gregory M, Atkin CL, Netzer KO, Weber M, Reeders S, Grönhagen-Riska C, Neumann HP, Trembath R, Tryggvason K: Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome. J Am Soc Nephrol. 1996, 7: 702-709.PubMed
21.
go back to reference Tonna S, Wang YY, Wilson D, Rigby L, Tabone T, Cotton R, Savige J: The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy. Pediatr Nephrol. 2008, 23: 2201-2207. 10.1007/s00467-008-0934-7.CrossRefPubMed Tonna S, Wang YY, Wilson D, Rigby L, Tabone T, Cotton R, Savige J: The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy. Pediatr Nephrol. 2008, 23: 2201-2207. 10.1007/s00467-008-0934-7.CrossRefPubMed
22.
go back to reference Voskarides K, Arsali M, Athanasiou Y, Elia A, Pierides A, Deltas C: Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria. Pediatr Nephrol. 2012, 27: 675-679. 10.1007/s00467-011-2084-6.CrossRefPubMed Voskarides K, Arsali M, Athanasiou Y, Elia A, Pierides A, Deltas C: Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria. Pediatr Nephrol. 2012, 27: 675-679. 10.1007/s00467-011-2084-6.CrossRefPubMed
23.
go back to reference Frascá GM, Soverini L, Gharavi AG, Lifton RP, Canova C, Preda P, Vangelista A, Stefoni S: Thin basement membrane disease in patients with familial IgA nephropathy. J Nephrol. 2004, 17: 778-785.PubMed Frascá GM, Soverini L, Gharavi AG, Lifton RP, Canova C, Preda P, Vangelista A, Stefoni S: Thin basement membrane disease in patients with familial IgA nephropathy. J Nephrol. 2004, 17: 778-785.PubMed
24.
go back to reference Yao XD, Chen X, Huang GY, Yu YT, Xu ST, Hu YL, Wang QW, Chen HP, Zeng CH, Ji DX, Hu WX, Tang Z, Liu ZH: Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis. Orphanet J Rare Dis. 2012, 7: 100-10.1186/1750-1172-7-100.CrossRefPubMedPubMedCentral Yao XD, Chen X, Huang GY, Yu YT, Xu ST, Hu YL, Wang QW, Chen HP, Zeng CH, Ji DX, Hu WX, Tang Z, Liu ZH: Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis. Orphanet J Rare Dis. 2012, 7: 100-10.1186/1750-1172-7-100.CrossRefPubMedPubMedCentral
25.
go back to reference Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M: Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002, 17: 1218-1227. 10.1093/ndt/17.7.1218.CrossRefPubMed Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M: Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002, 17: 1218-1227. 10.1093/ndt/17.7.1218.CrossRefPubMed
26.
go back to reference Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC: X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol. 2003, 14: 2603-2610. 10.1097/01.ASN.0000090034.71205.74.CrossRefPubMed Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC: X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol. 2003, 14: 2603-2610. 10.1097/01.ASN.0000090034.71205.74.CrossRefPubMed
27.
go back to reference Rheault MN, Kren SM, Hartich LA, Wall M, Thomas W, Mesa HA, Avner P, Lees GE, Kashtan CE, Segal Y: X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome. Nephrol Dial Transplant. 2010, 25: 764-769. 10.1093/ndt/gfp551.CrossRefPubMed Rheault MN, Kren SM, Hartich LA, Wall M, Thomas W, Mesa HA, Avner P, Lees GE, Kashtan CE, Segal Y: X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome. Nephrol Dial Transplant. 2010, 25: 764-769. 10.1093/ndt/gfp551.CrossRefPubMed
28.
go back to reference Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013, 369: 1502-1511. 10.1056/NEJMoa1306555.CrossRefPubMedPubMedCentral Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM: Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013, 369: 1502-1511. 10.1056/NEJMoa1306555.CrossRefPubMedPubMedCentral
Metadata
Title
Whole exome sequencing reveals novel COL4A3 and COL4A4mutations and resolves diagnosis in Chinese families with kidney disease
Authors
Fujun Lin
Fan Bian
Jun Zou
Xiangru Wu
Jianping Shan
Wei Lu
Yao Yao
Gengru Jiang
Daniel Philip Gale
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-175

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.